Levels helps you see how food affects your health. By leveraging data shared by members from biosensors like continuous glucose monitors (CGM), Levels provides real-time feedback on how diet and lifestyle choices impact your metabolic health. Our Members are using personalized data to discover their optimal diet, control their weight, and reduce long-term health risk.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/21/22 | $38,000,000 | Series A |
A16z Andrea Funsten Ben Gilbert David Rosenthal Lenny Rachitsky Mario Gabriele Mat Fraser Moshe Lifschitz Niv Dror Shrug Capital Trust Ventures | $300,000,000 |
| 02/01/23 | $7,000,000 | Series A Extension |
TriplePoint Capital | undisclosed |
